Data / Form D filings / BRT Biotechnologies, Inc.
BRT Biotechnologies, Inc.: Form D filings
BRT Biotechnologies, Inc., a biotechnology company in Claremont, CA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on May 8, 2026, reports $607,300 sold of a $607,300 offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SEAVER NORTH 645 N COLLEGE AVE, Claremont, CA, 91711
- Phone
- (909) 447-9472
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1994719
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | New notice | $607,300 | $607,300 | 12 | Mar 5, 2025 | sec.gov | |
| Oct 26, 2023 | Amendment | $300,000 | $272,500 | $27,500 | 7 | Sep 20, 2023 | sec.gov |
| Oct 5, 2023 | New notice | $200,000 | $162,500 | $37,500 | 5 | Sep 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jane Liu | Executive Officer, Director | |
| Gregory Copeland | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 4, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BRT Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.